Proteocyte AI

Each year, 450,000 people worldwide are diagnosed with Oral Cancer with a staggering 50% mortality rate - 1 person dies every 45 minutes in North America – largely due to LATE detection and treatment. Enter STRATICYTE™ by Proteocyte AI – a revolutionary prognostic test that changes the game. Using AI-driven biomarker analysis and digital pathology, STRATICYTE™ delivers an objective 5-year personalized risk score (97% sensitivity/NPV), detects high-risk lesions earlier and reduces overtreatment.